Abstract |
Preterm birth (PTB), defined as any birth occurring before 37 weeks of gestation, occurs in only 12% of all births, yet accounts for nearly half of long-term neurological morbidity, and 60%-80% of perinatal mortality. The single most common cause of PTB is intrauterine infection. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide that is both upregulated by inflammatory cytokines and capable of increasing myometrial smooth muscle tone. We hypothesized, therefore, that ET-1 is a critical component of the parturition cascade in the setting of infection-associated PTB. In our previous work, we have shown that blockade of ET-1 synthesis through the use of the metalloproteinase inhibitor phosphoramidon results in control of preterm labor. In the current work, we showed that blockade of ET-1 action with 5-50 mg/kg i.p. 3-(3-carboxybenzyl)-1-((6-ethylbenzo[d][1,3]dioxol-5-yl)methyl)-6-hydroxy-4-oxo-1,4-dihydroquinoline-2- carboxylic acid ( HJP272), a putative novel selective ETA-receptor antagonist (IC50, 70 nmol/L), prevents PTB induced with up to 50 mg/kg of i.p. lipopolysaccharide in a mouse model. This is the first report, to our knowledge, of control of infection-associated PTB with a specific ETA-receptor antagonist. The identification of a novel effective therapy for PTB could have important clinical implications.
|
Authors | Nicole Olgun, Hardik J Patel, Ralph Stephani, Wei Wang, Haoting Yen, Sandra E Reznik |
Journal | Canadian journal of physiology and pharmacology
(Can J Physiol Pharmacol)
Vol. 86
Issue 8
Pg. 571-5
(Aug 2008)
ISSN: 0008-4212 [Print] Canada |
PMID | 18758506
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- 3-(3-carboxybenzyl)-1-((6-ethylbenzo(d)(1,3)dioxol-5-yl)methyl)-6-hydroxy-4-oxo-1,4-dihydroquinoline-2-carboxylic acid
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Hydroxyquinolines
- Lipopolysaccharides
- Receptor, Endothelin A
- Receptor, Endothelin B
|
Topics |
- Animals
- Binding, Competitive
(drug effects)
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Female
- Hydroxyquinolines
(pharmacology)
- Lipopolysaccharides
(toxicity)
- Mice
- Mice, Inbred C57BL
- Pregnancy
- Pregnancy Complications, Infectious
(prevention & control)
- Premature Birth
(chemically induced, etiology, prevention & control)
- RNA Interference
- Receptor, Endothelin A
(metabolism)
- Receptor, Endothelin B
(metabolism)
|